TPG Capital

TPG Capital is a global private equity firm with a healthcare team operating out of London that focuses on European deals, particularly large consolidations across care delivery and pharma/therapeutics. This is one of the largest pools of healthcare PE capital in the world, and the London team is the entry point for European founders, take-privates, or carve-outs. AI is not the explicit thesis; TPG underwrites deals based on scale, market position, and operational improvement potential, with technology as an enabler.

The fund deploys checks of $25M and above at the growth stage, with individual transactions often running into hundreds of millions or more. That positions the team for buyouts, take-privates, large minority growth investments, and platform-and-bolt-on consolidations. Founders running small or early-stage companies will not be the right fit.

Founders should approach TPG when they run a large healthcare business — care delivery, pharma services, or therapeutics platforms — that needs a substantial capital partner for consolidation, take-private, or carve-out scenarios. Venture-stage and even most growth-stage companies are too small. Expect institutional diligence, multiple workstreams, and a partner that thinks about market consolidation, regulatory exposure across jurisdictions, and exit through strategic sale or IPO. Use the London office as the appropriate point of entry for European deals; the broader TPG platform brings operating partners, capital markets relationships, and the ability to underwrite complex transactions. Come prepared.